Literature DB >> 20237414

Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.

Ileana Bortolomai1, Silvana Canevari, Ileana Facetti, Loris De Cecco, Giancarlo Castellano, Alberto Zacchetti, Malcolm R Alison, Silvia Miotti.   

Abstract

To investigate the tumor fraction with cancer stem/tumor initiating cell (CSC/TIC) characteristics, we tested the human cervical carcinoma cell lines A431, Caski and SiHa, by growth as non-adherent spheres in specific media and aldehyde dehydrogenase (ALDH) enzymatic activity. A good correlation between the two parameters was observed and the highest levels were observed in A431 cell line that was selected for characterization of the CSC/TIC fraction. A431 parental cells already displayed characteristics common to CSC/TIC, such as sphere forming efficiency, adherent holoclone formation and high ALDH activity. Non-adherent spheres maintained or increased these properties, and, in particular, ALDH-positive fraction increased from 46 to 65% and a transient induction of stem cell markers such as Nanog, Nestin and Oct4 was observed. Furthermore, a significant increase of paraclone forming cells was observed, suggesting that differentiation took place inside sphere cell populations. As compared to parental cells, spheres were characterized by: (1) a ten-fold higher verapamil-sensitive side population fraction; (2) the appearance of a podoplanin-positive subpopulation characterized by a small cell size; (3) the ability to propagate tumors in nude mice at a lower cell dose. The global gene expression analysis demonstrated a strong and reversible modulation of 'sphere' phenotype in comparison to parental and sphere cells re-induced to adherent conditions. All together our results indicated that the growth of A431 cells as a non-adherent sphere was not sufficient by itself to define a stem-like population, but it was essential for the emergence of a small population of tumor cells with CSC properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237414     DOI: 10.4161/cc.9.6.11108

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  38 in total

Review 1.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Zenya Naito
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 2.  The role of human aldehyde dehydrogenase in normal and cancer stem cells.

Authors:  Irene Ma; Alison L Allan
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 3.  Cervical cancer stem cells: opportunities and challenges.

Authors:  Ravindresh Chhabra
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

Review 4.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

5.  H460 non-small cell lung cancer stem-like holoclones yield tumors with increased vascularity.

Authors:  Eugene Manley; David J Waxman
Journal:  Cancer Lett       Date:  2013-12-12       Impact factor: 8.679

6.  Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.

Authors:  Linda S Steelman; Patrick Navolanic; William H Chappell; Stephen L Abrams; Ellis W T Wong; Alberto M Martelli; Lucio Cocco; Franca Stivala; Massimo Libra; Ferdinando Nicoletti; Lyudmyla B Drobot; Richard A Franklin; James A McCubrey
Journal:  Cell Cycle       Date:  2011-09-01       Impact factor: 4.534

7.  Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines.

Authors:  Tian Liao; Andreas M Kaufmann; Xu Qian; Voramon Sangvatanakul; Chao Chen; Tina Kube; Guoyou Zhang; Andreas E Albers
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-23       Impact factor: 4.553

8.  A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth.

Authors:  Nan Xiao; Hongbin Cao; Che-Hong Chen; Christina S Kong; Rehan Ali; Cato Chan; Davud Sirjani; Edward Graves; Albert Koong; Amato Giaccia; Daria Mochly-Rosen; Quynh-Thu Le
Journal:  Clin Cancer Res       Date:  2013-06-28       Impact factor: 12.531

Review 9.  Cancer stem cells and cell size: A causal link?

Authors:  Qiuhui Li; Kiera Rycaj; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2015-08-01       Impact factor: 15.707

10.  STAT3 correlates with stem cell-related transcription factors in cervical cancer.

Authors:  Hua Wang; Hong-Bing Cai; Lou-Lou Chen; Wen-Jun Zhao; Pan Li; Zhi-Qiang Wang; Zhen Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.